|
|
 |
|
Viewing report
|
|
|
|
Inhaled Pain Management: Products, Therapeutics, Markets and Forecasts
Greystone Associates, May 2011
As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to inhalable formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, inhaled pain drug delivery addresses a key healthcare issue – one that is particularly problematic in aging populations and developing economies. Several of these development programs involve international partnerships designed to take advantage of perceived opportunities in regional markets.
Highlights
- Analyzes and evaluates intranasal and orally inhaled pain management products and pipeline candidates and assesses the market potential for existing and probable future products
- Examines inhalation product technology issues and evolving market factors for inhaled pain management therapeutics
- Provides detailed assessments of market segments and growth prospects
- Provides market data and forecasts to 2015
- Profiles inhaled pain management market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
